Phenobarbital Modifies Antitumor Effect of Cyclophosphamide Depending on the Type of Tumor Cell Death Caused by It

被引:0
|
作者
V. I. Kaledin
V. P. Nikolin
T. Yu. Baimak
M. R. Galyamova
N. A. Popova
E. M. Andreeva
机构
[1] Institute of Cytology and Genetics,Siberian Branch of Russian Academy of Sciences
[2] Novosibirsk State University,undefined
来源
Bulletin of Experimental Biology and Medicine | 2003年 / 135卷
关键词
transplanted tumors; cyclophosphamide; phenobarbital; apoptosis; necrosis;
D O I
暂无
中图分类号
学科分类号
摘要
Antitumor effect of cyclophosphamide on LS and P388 tumors is realized via apoptosis and on HA-1 and Krebs-2 tumors resistant to apoptosis via necrosis of tumor cells. Phenobarbital induction of cyclophosphamide-metabolizing enzymes decreases and cimetidine inhibition potentiates the effect of cyclophosphamide on LS and P388 cells and does not modulate the effect on HA-1 and Krebs-2 cells. Presumably, apoptosis and necrosis of tumor cell are induced by different cyclophosphamide metabolites.
引用
收藏
页码:289 / 292
页数:3
相关论文
共 50 条
  • [1] Phenobarbital modifies antitumor effect of cyclophosphamide depending on the type of tumor cell death caused by it
    Kaledin, VI
    Nikolin, VP
    Baimak, TY
    Galyamova, MR
    Popova, NA
    Andreeva, EM
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2003, 135 (03) : 289 - 292
  • [2] Augmentation of antitumor effect of endogenously induced tumor necrosis factor by cyclophosphamide
    Inagawa, H
    Ohshiro, S
    Nishizawa, T
    Goto, S
    Soma, GI
    Mizuno, DI
    ANTICANCER RESEARCH, 1997, 17 (1A) : 55 - 60
  • [3] CYCLOPHOSPHAMIDE MODIFIES THE INDUCTION KINETICS BUT NOT CELL-TYPES AND CYTOTOXIC MECHANISMS OF ANTITUMOR CELLS ELICITED WITH OK-432 PLUS ATTENUATED TUMOR-CELLS
    RYOYAMA, K
    RYOYAMA, C
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1991, 34 (03) : 143 - 149
  • [4] Caspase inhibition in apoptotic T cells triggers necrotic cell death depending on the cell type and the proapoptotic stimulus
    Scheller, C
    Knöferle, J
    Ullrich, A
    Prottengeier, J
    Racek, T
    Sopper, S
    Jassoy, C
    Rethwilm, A
    Koutsilieri, E
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2006, 97 (06) : 1350 - 1361
  • [5] Cyclophosphamide Potentiates the Antitumor Effect of Immunization with Injection of Immature Dendritic Cells into Irradiated Tumor
    Park, You-Soo
    Bae, Jae-Ho
    Son, Chool-Hun
    Lee, Kyung-Soo
    Kim, Wontaek
    Jung, Min Ho
    Yang, Kwangmo
    Kim, Sun-Hee
    Kang, Chi-Dug
    IMMUNOLOGICAL INVESTIGATIONS, 2011, 40 (04) : 383 - 399
  • [6] Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine
    Ji-Yan Liu
    Yang Wu
    Xiao-Shi Zhang
    Jin-Liang Yang
    Hong-Li Li
    Yong-Qiu Mao
    Yi Wang
    Xia Cheng
    Yong-Qiang Li
    Jian-Chuan Xia
    Maria Masucci
    Yi-Xin Zeng
    Cancer Immunology, Immunotherapy, 2007, 56 : 1597 - 1604
  • [7] Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine
    Liu, Ji-Yan
    Wu, Yang
    Zhang, Xiao-Shi
    Yang, Jin-Liang
    Li, Hong-Li
    Mao, Yong-Qiu
    Wang, Yi
    Cheng, Xia
    Li, Yong-Qiang
    Xia, Jian-Chuan
    Masucci, Maria
    Zeng, Yi-Xin
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (10) : 1597 - 1604
  • [8] A novel N-alkylated prodigiosin analogue induced death in tumour cell through apoptosis or necrosis depending upon the cell type
    Amit A. Deorukhkar
    Ramesh Chander
    Ruchi Pandey
    Krishna B. Sainis
    Cancer Chemotherapy and Pharmacology, 2008, 61
  • [9] A novel N-alkylated prodigiosin analogue induced death in tumour cell through apoptosis or necrosis depending upon the cell type
    Deorukhkar, Amit A.
    Chander, Ramesh
    Pandey, Ruchi
    Sainis, Krishna B.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (03) : 355 - 363
  • [10] Tumor-specificity and type of cell death induced by trihaloacetylazulenes in human tumor cell lines
    Sekine, Takashi
    Takahashi, Juri
    Nishishiro, Masayuki
    Arai, Atsuhiro
    Wakabayashi, Hidetsugu
    Kurihara, Teruo
    Kobayashi, Masaki
    Hashimoto, Ken
    Kikuchi, Hirotaka
    Katayama, Tadashi
    Kanda, Yumiko
    Kunii, Shiro
    Motohashi, Noboru
    Sakagami, Hiroshi
    ANTICANCER RESEARCH, 2007, 27 (1A) : 133 - 143